The isolated pancreatic islet as a micro-organ and its transplantation to cure diabetes: Celebrating the legacy of Paul Lacy

Islets

Volumn 2, Issue 4, 2010, Pages 210-224

  Misler, Stanley ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes mellitus; Glucagon secretion; Insulin secretion; Paul Lacy; Physiology of islets of Langerhans; Transplantation of islets of Langerhans

Indexed keywords

ACETYLCHOLINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUCAGON; PROTEIN G;

ALLOTRANSPLANTATION; AUTOIMMUNITY; CELL INTERACTION; DIABETES MELLITUS; ELECTRON TOMOGRAPHY; ENDOCRINE CELL; ENDOCRINE GLAND; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET TRANSPLANTATION; REVIEW; STIMULUS SECRETION COUPLING; SURGICAL TECHNIQUE; VEIN CATHETERIZATION;

CELL SEPARATION; DIABETES MELLITUS; ENDOCRINOLOGY; HISTORY, 20TH CENTURY; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MODELS, BIOLOGICAL; ORGAN SIZE;

EID: 77957070339     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.2.4.12156     Document Type: Review

References (109)

1. Latta P, Ricordi C, Scharp D. Paul E. Lacy MD, PhD, February 7, 1924-February 15, 2005. Am J Transplant 2005; 5:976-7.
2. Hellerstrom C. The life story of the pancreatic B cell. Diabetologia 1984; 26:393-400.
3. Lacy PE, Kostianovsky M. A method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967; 16:35-9.
4. Howell SL, Fink CJ, Lacy PE. Isolation and properties of secretory granules from rat islets of Langerhans I. Isolation of a secretory granule fraction. J Cell Biol 1969; 41:154-61.
5. Ashcroft SJ, Weerasinghe LC, Randle PJ. Interrelationship of islet metabolism, adenosine triphosphate content and insulin release. Biochem J 1973;132:223-31.
6. Grodsky GM, Bennett LL. Cation requirements for insulin secretion in the isolated perfused pancreas. Diabetes 1966; 15:910-3.
7. Curry DL, Bennett LL, Grodsky GM. Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology 1968; 83:572-84.
8. Dean PM, Mathews EK, Sakamoto Y. Pancreatic islet cells: effects of monosaccharides, glycolytic intermediates and metabolic inhibitors on membrane potential and electrical activity. J Physiol 1975; 246:459-78.
9. Kostianovsky M, McDaniel ML, Still MF, Codilla RC, Lacy PE. Monolayer cell culture of adult rat islets of Langerhans. Diabetologia 1974; 10:337-44.
10. Lacy PE, Howell SL, Young DA, Fink CJ. A new hypothesis of insulin secretion. Nature 1968; 219:1177-80.
11. Marchetti P, Scharp DW, Mc Lear M, Gingerich R, Finke E, Olack B, et al. Pulsatile insulin secretion from isolated human pancreatic islets. Diabetes 1994; 43:827-30.
12. Ashcroft FM, Rorsman P. Electrophysiology of the pancreatic beta cell. Prog Biophy Mol Biol 1991; 54:87-141.
13. Misler S, Barnett DW, Gillis KG, Pressel DM. Electrophysiology of stimulus-secretions coupling in human beta-cells. Diabetes 1992; 41:1221-8.
14. Grynkiewicz G, Poenie M, Tsien RY. A new generation of calcium indicators with greatly improved fluorescent properties. J Biol Chem 1985; 260:3440-50. (Pubitemid 15114340)
15. Seino S. ATP-sensitive potassium channels: model of heteromultimeric potassium channel receptor assemblies. Annual Rev Physiol 1999; 61:337-61.
16. Gillis KD, Misler S. Single cell assay of exocytosis from pancreatic islet B cells. Pfluegers Arch-EJP 1992; 420:121-3.
17. Ammala C, Eliasson L, Bokvist K, Larsson O, Ashcroft FM, Rorsman P. Exocytosis elicted by action potentials and voltage clamp calcium currents in individual mouse pancreatic beta cells. J Physiol 1993; 472:655-88. (Pubitemid 24015025)
18. Smith PA, Duchen MR, Ashcroft FM. A fluorometric and amperometric study of calcium and secretion in islolated mouse pancreatic beta-cells. Pfluegers Arch-EJP 1995; 430:808-18.
19. Zhou Z, Misler S. Amperometric detection of quantal secretion from patch-clamped rat pancreatic beta cells. J Biol Chem 1996; 271:270-7.
20. Huang L, Shen H, Atkinson MA, Kennedy RT. Detection of exocytosis at individual pancreatic beta cells by amperometry at a chemically modified microelectrode. Proc Natl Acad Sci 1995; 92:9608-12.
21. Barg S, Ma X, Eliasson L, Galvanovskis J, Goepel SO, Obermuller S, et al. Fast exocytosis with few calcium channels in insulin secreting mouse pancreatic beta cells Biophys J 2001; 81:3308-23.
22. Gromada J, Bokvist K, Ding WG, Holst JJ, Nielsen JH, Rorsman P. Glucagon-like peptide 7-37 amide stimulated exocytosis in human pancreatic beta-cells by both proximal and distal steps in stimulus-secretion coupling. Diabetes 1998; 47:57-65.
23. Silva AM, Dickey AS, Barnett DW, Misler S. Ion channels underlying stimulus-secretion coupling and its cell-cell variety in beta cell of transplantable porcine islets of Langerhans. Channels 2009; 3:91-100.
24. Yang Y, Gillis KD. A highly Ca-sensitive pool of granules is regulated by glucose and protein kinase in insulin-secreting INS-1 cells. J Gen Physiol 2004; 124:641-51. (Pubitemid 39628132)
25. Misler S, Zhou Z, Dickey AS, Silva AM, Pressel DM, Barnett DW. Electrical activity and exocytotic correlates of biphasic insulin secretion from beta-cell of canine islets of Langerhans. Channels 2009; 3:1811-93.
26. Pedersen MG, Sherman A. Newcomer insulin secretory granules as a highly calcium sensitive pool. Proc Natl Acad Sci USA 2009; 106:7432-6.
27. Thurmond DC, Gonelle-Gispert C, Furukawa M, Halban PA, Pessin JE. Glucose stimulated insulin secretion is coupled to the interaction of actin with the t-SNARE (target membrane soluble N-ethylmaleimid-esensitive factor attachment protein receptor protein) complex. Mol Endocrinol 2003; 17:732-42.
28. Barg S, Olofsson CS, Schreiver-Abein J, Wendt A, Gebre-Medhin S, Renstroem E, et al. Delay between fusion pore opening and peptide release from large dense core vesicles in neuroendocrine cells. Neuron 2002; 33:287-99.
29. Ma L, Bindokas VP, Kuznetsov A, Rhodes C, Hays L, Edwardson JM, et al. Direct imaging shows that insulin granule exocytosis occurs by complete vesicle fusion. Proc Natl Acad Sci 2004; 101:9266-71.
30. Ohara-Imaizumi M, Nakamichi Y, Tanaka T, Ishida H, Nagamatsu S. Imaging exocytosis of single insulin secretory granules with evanescent wave microscopy. J Biol Chem 2002; 277:3805-8.
31. Michael DJ, Geng X, Cawley NX, Loh YP, Rhodes CJ, Drain P, et al. Fluorescent cargo proteins in pancreatic beta cells: design determines secretion kinetics as exocytosis. Biophys J 2004; 87:3-5.
32. Michael DJ, Xiong W, Geng X, Drain P, Chow RH. Human insulin vesicle dynamics during pulsatile secretion. Diabetes 2007; 56:1277-88. (Pubitemid 46715608)
33. Braun M, Wendt A, Birnir B, Broman J, Elliasson L, Galvanovskis J, et al. Regulated exocytosis of GABA-containing synaptic microvesicles in pancreatic beta-cells. J Gen Physiol 2004; 123:191-204.
34. Goepel SO, Kanno T, Barg S, Weng X-G, Gromada J, Rorsman P. Regulation of glucagon release in mouse alpha-cells by KATP channels and inactivation of TTX-sensitive Na channels. J Physiol 2000; 528:509-20.
35. Wendt A, Birnir B, Busschard K, Gromada J, Salehi A, Sewing S, et al. Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells. Diabetes 2004; 53:1038-45.
36. Braun M, Ramracheya R, Amisten S, Bengtsson M, Moritoh Y, Zhang Q, et al. Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells. Diabetologia 2009; 52:1566-78.
37. Ashcroft FM. ATP-sensitive channnelopathties: focus on insulin secretion. J Clin Invest 2005; 115:2047-58.
38. Nichols CG. K-ATP channnels as molecular sensors of cell metabolism. Nature 2006; 4449:470-6.
39. Hattersley AT, Ashcroft FM. Activating mutations of Kir6.2 and neonatal diabetes: clinical syndromes, new clinical insights and new therapy. Diabetes 2005; 54:2503-13.
40. Atkinson MA. Thirty years of investigating the autoimmune basis for type 1diabetes: why can't we prevent or reverse this disease? Diabetes 2005; 54:1253-63.
41. Hoppa MB, Collins S, Ramracheya R, Hodson L, Amisten S, Zhang Q, et al. Chronic palmitate exposure inhibits insulin secretion by dissociation of Ca channels from secretory granules. Cell Metabolism 2009; 10:455-65.
42. Misler S, Dickey A, Barnett DW. Maintenance of stimulus- secretion coupling and single beta-cell function in cryopreserved-thawed human islets of Langerhans. Pfluegers Arch-EJP 2005; 450:395-405.
43. Williamson JR, Lacy PE, Grieder JW. Ultrastructural changes in islets of the rat produced by tolbutamide. Diabetes 1961; 10:460-9.
44. Benninger RKP, Zhang M, Head S, Satin Ls, Piston DW. Gap junction coupling and calcium waves in pancreatic islets. Biophys J 2008; 95:5048-61.
45. Janney CG, Davie JM, Lacy PE, Finke EH. Characterization of lymphocytes from rejected and non-rejected islet xenografts. Transplantation 1982; 33:585-7.
46. Lacy PE, Finke EH. Activation of intra-islet cells causes destruction of islet cells. Am J Path 1991; 138:1183-90.
47. Wong FS, Janeway CA. Insulin-dependent diabetes mellitus and its animal models. Curr Opinion Immunol 1999; 11:643-7.
48. Janeway CA. How the immune system protects the host from infection. Microbes Infect 2001; 3:1167-71.
49. Pipeleers D. The bio-sociobiology of pancreatic beta cells. Diabetologia 1987; 30:277-91.
50. Lacy PE, Howell SL, Young DA, Fink CJ. A new hypothesis of insulin secretion. Nature 1968; 219:1177-80.
51. Lacy PE, Young DA, Fink CJ. Studies on insulin secretion in vitro from isolated islets of the rat pancreas. Endocrinology 1968; 83:1155-61.
52. Bonner-Weir S. Beta-cell turnover: its assessment and implications. Diabetes 2001; 50:20-4.
53. Martin JM, Gregor WH, Lacy PE, Evens RG. The effect of hyperglycemia upon islet regeneration in rats. Diabetes 1963; 12:538-44.
54. Martin JM, Lacy PE. The prediabetic period in partially pancreatectomized rats. Diabetes 1963; 12:238-42.
55. Teuscher AU, Kendall DM, Smets YPC, Leone JP, Sutherland DER, Robertson RP. Successful islet auto-transplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes 1998; 47:324-30.
56. Pericin M, Althage A, Freigang S, Hengartner H, Rolland E, Dupraz P, et al. Allogeneic b-cells correct diabetes and resist immune rejection. Proc Natl Acad Sci USA 2002; 99:8203-6.
57. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for the isolation of human pancreatic islets. Diabetes 1988; 3:413-20. (Pubitemid 18096377)
58. Ballinger WF, Lacy PE. Transplantation of intact pancreatic islets in rats. Surgery 1972; 72:175-86.
59. Kemp CB, Knight MJ, Scharp DW, Ballinger WF, Lacy PE. Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats. Diabetologia 1973; 9:486-91.
60. Kemp CB, Knight MJ, Scharp DW, Ballinger WF, Lacy PE. Transplantation of isolated pancreatic islets into the portal vein of diabetic rats. Nature 1973; 244:447-53.
61. Pipeleers-Marichal MA, Pipeleers DG, Cutler J, Lacy PE, Kipnis DM. Metabolic and morphologic studies on intraportal islet transplanted rats. Diabetes 1976; 25:1041-51.
62. Markmann JF, Rosen M, Siegelman ES, Soulen MC, Deng S, Barker CF, et al. Magnetic resonance - defined periaortal stenosis following intraportal islet transplantation. Diabetes 2003; 52:1501-94.
63. Inveradi L, Kenyon NS, Ricordi C. Islet transplantation: immunological perspectives. Current Opin. Immunol 2003; 15:507-11.
64. Lacy PE. Workshop on pancreatic islet cell transplantation in diabetes. Diabetes 1978; 27:427-9.
65. Scharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Falqui L, et al. Insulin independence after islet transplantation into Type I diabetic patient. Diabetes 1990; 39:515-8.
66. Shapiro AMJ, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type I diabetes mellitus using a glucocorticoid free immunosuppressive regimen. N Engl J Med 2000; 343:230-8.
67. Froud T, Ricordi C, Baidal DA, Hafiz MM, Ponte G, Cure P, et al. Islet transplantation in diabetes mellitus using cultured islets and steroid free immunosuppression: Miami experience. Am J Transplant 2005; 5:2037-46.
68. Ryan FA, Paty BW, Senior PA, Brgan D, Alfadhli E, Kneteman NM, et al. Five year follow-up after clinical islet transplantation. Diabetes 2005; 54:2060-9. (Pubitemid 40911269)
69. Shapiro AMJ, Ricordi C, Hering BJ, Aucincloss H, Lindblad R, Robertson RP, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2005; 355:1318-30.
70. Fiorina P, Shapiro AMJ, Ricordi C, Secchi A. The clinical impact of islet transplantation. Am J Transplant 2008; 8:1990-7.
71. Ricordi C, Strom TB. Clinical islet transplantation: advances and immunological challenges. Nature 2004; 4:259-68.
72. Robertson RP. Islet transplantation as a treatment for diabetes - a work in progress. N Engl J Med 2004; 350:694-705. (Pubitemid 38364628)
73. Carlsson PO, Andersson A, Carlsson C, Hellerstrom C, Hoglund E, King A, et al. Engraftment and growth of transplanted pancreatic islets. Ups J Med Sci 2000; 105:107-23.
74. Jansson L, Carlsson PO. Graft vascular function after transplantation of pancreatic islets. Diabetologia 2002; 45:749-63.
75. Bennet W, Groth CG, Larsson R, Nilsson B, Korsgren O. Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes Ups. J Med Sci 2000; 105:125-40.
76. Johansson U, Rasmusson I, Niclou SP, Forslund N, Gustavsson L, Nilsson B, et al. Formation of composite endothelial cell-mesenchymal stem cell-islets: a novel approach to islet vascularization. Diabetes 2004; 57:2393-401.
77. Mattsson G, Jannson L, Nordin A, Andersson A, Carisson PO. Evidence of functional impairment of syngeneically transplanted mouse pancreatic islets retrieved from the liver. Diabetes 2004; 53:948-54
78. Wang J, Cao Y, Chen Y, Chen Y, Gardner P, Steiner DF. Pancreatic beta cells lack a low glucose and O2-inducible mitochondrial protein that augments cell survival. Proc Natl Acad Sci USA 2006; 103:10636-41. (Pubitemid 44078029)
79. Korsgren O, Lundgren T, Felldin M, Foss A, Isakson B, Permert J, et al. Optimizing islet engraftment is critical for successful islet transplantation. Diabetologia 2008; 51:227-32.
80. Medarova Z, Moore M. A MRI as a tool to monitor islet transplantation. Nat Rev Endocrinol 2009; 5:444-52.
81. Paty BW, Ryan EA, Shapiro AMJ, Lakey JRT, Robertson RP. Intra-hepatic islet transplantation in type 1 diabetic patient does not restore hypoglycemic hormonal counter-regulation or symptom recognition after insulin independence. Diabetes 2002; 51:3428-34.
82. Street CN, Lakey JRT, Shapiro AJM, Imes S, Rjotte RV, Ryan EA, et al. Islet graft assessment in the Edmonton protocol: Implications for predicting longterm clinical outcome. Diabetes 2004; 53:3107-14.
83. Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song KH, Sharma A, O'Neil JJ. In vitro cultivation of human islets from expanded ductal tissue. Diabetes 2000; 97:7999-8004.
84. Burke GW, Ciancio G, Sollinger HW. Advances in pancreas transplantation. Transplantation 2004; 77:62-7.
85. Ferrannini E, Camastra S, Gastaldelli A, Sironi AM, Natali A, Muscelli E, et al. Beta-cell function in obesity: Effects of weight loss. Diabetes 2004; 53:26-33.
86. Dufane D, Gianello P. Pig islets for xenotransplantation. Curr Opin Nephr Hypertens 2009; 18:4950-500.
87. Hunter P. Xeno's paradox. EMBO Reports 2009; 10:554-7.
88. Garavenko O, Croxson MC, Irgang M, Karlas A, Denner J, Elliot RB. Monitoring for the presence of potentially xenotic viruses in recipients of pig islet xenotransplantation. Clin Microbiology 2004; 42:5336-53.
89. Lacy PE. Treating diabetes with transplanted cells. Scientific American 1995.
90. Lanza RP, Chick WL. Encapsulated cell therapy. Scientific American: Science and Medicine 1995.
91. Scharp DW, Swanson CJ, Olack BJ, Latta PP, Hegre OD, Doherty EJ, et al. Protection of encapsulated human islets implanted without immunosuppression in patients with type I or type II diabetes and in non-diabetic control subjects. Diabetes 1994; 43:1167-70.
92. Schneider S, Feilen PJ, Brunnenmeier F, Minnemann T, Zimmermann H, Zimmermann U, et al. Long-term graft function of adult rat and human islets encapsulated in novel alginate-based microcapsules after transplantation in immunocompetent diabetic mice. Diabetes 2005; 54:687-93.
93. Hering BJ, Wijkstrom M, Graham ML, Hårdstedt M, Aasheim TC, Jie T, et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nature Medicine 2006; 12:301-3.
94. Hering BJ, Walawalkar N. Pig-to-nonhuman primate islet xenotransplantation. Transplant Immunol 2009; 38:204-12.
95. Dor Y, Brown J, Martines OI, Melton DA. Adult pancreatic beta cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004; 429:41-7.
96. Zhou Q, Melton DA. Pathways to new beta cells Cold Spring Harbor Symposium on Quantitative Biology 2008; 73:175-81.
97. Seaberg RM, Smukler SR, Kieffer TJ, Enikolopov G, Asghar Z, Wheeler MB, et al. Clone identification of multipotent precursors from adult mouse pancreas that generated neural and pancreatic lineages. Nature Biotechnol 2004; 22:1115-24.
98. Todorov I, Omori K, Pascual M, Rawson J, Nair I, Valiente L, et al. Generation of human islets through expansion and differentiation of non-islet pancreatic cells discarded after islet isolation. Pancreas 2006; 32:130-8.
99. Hao E, Bjorn T, Itkin-Ansari P, Lakey Jonathan RT, Ifat G, Monosov E, et al. Beta-cell differentiation from non-endocrine epithelial cells of the adult human pancreas. Nature Medicine 2006; 12:310-6. (Pubitemid 43355079)
100. Lechner A, Yang YG, Blacken RA, Wang L, Nolan AL, Habener JF. No evidence for significant transdifferentiation of bone marrow into pancreatic beta cells in vivo. Diabetes 2004; 56:616-23. (Pubitemid 38270630)
101. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton A. In vivo reprogramming of adult pancreatic exocrine cells to beta cells. Nature 2008; 455:627-33.
102. Narushima M, Kobayashi N, Okitsu T, Tanaka Y, Li S, Chen Y, et al. A human beta-cell line for transplantation therapy to control type 1 diabetes. Nature Biotechnology 2005; 23:1274-82.
103. Weir GC, Bonner-Weir S. Beta cell precursors - a work in progress. Nature Biotechnology 2004; 22:1095-7.
104. Weir GC, Bonner-Weir S. Five stages of evolving beta cell dysfunction during its progression to diabetes. Diabetes 2004; 53:16-21.
105. Elzirik DL, Korbutt GS, Hellerstrom C. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta cell function. Am Soc Clin Invest 1992; 90:1263-8.
106. Laybutt DR, Glandt M, Xu G, Ahn YB, Trivedi N, Bonner-Weir S, et al. Critical reduction in Beta cell mass results in two distinct outcomes over time. J Biological Chem 2003; 278:2997-3005.
107. Donath MY, Halban PA. Decreased beta-cell mass I diabetes: significance, mechanisms and therapeutic implications. Diabetologia 2004; 47:581-9.
108. Pileggi A, Fenjves ES, Klei D, Ricordi C, Pastori RL. Protecting pancreatic Beta-cells. Life 2004; 56:387-94.
109. Nichols J, Cooke A. Overcoming self-destruction in the pancreas. Current Opinions in Biotechnology 2009; 20:511-5.